Presentations, studies, and other data showing risk–benefit estimates and rates of myocarditis following COVID-19 vaccination.
Key:
Myocarditis After COVID-19 Vaccination: Risk–Benefit Estimates and Incidence Over Time
The incidence of myocarditis after COVID-19 vaccination has become clearer over time.
A health care worker prepares a Moderna COVID-19 vaccine at the vaccination centre Hall Victor Hugo in Luxembourg on Jan. 21, 2021. Jean-Christophe Verhaegen/AFP via Getty Images
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
